Cytostatic sensitivity and MDR in bladder carcinoma cells: implications for tumor therapy. (Record no. 10736761)

MARC details
000 -LEADER
fixed length control field 01575 a2200421 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250513210354.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200006s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0946-1965
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.5414/cpp38204
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Schuldes, H
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20000626
245 00 - TITLE STATEMENT
Title Cytostatic sensitivity and MDR in bladder carcinoma cells: implications for tumor therapy.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. International journal of clinical pharmacology and therapeutics
Date of publication, distribution, etc. Apr 2000
300 ## - PHYSICAL DESCRIPTION
Extent 204-8 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Calcium Channel Blockers
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Carcinoma, Transitional Cell
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cisplatin
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Doxorubicin
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Resistance, Multiple
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Resistance, Neoplasm
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Synergism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Electron Spin Resonance Spectroscopy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Methotrexate
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Tumor Cells, Cultured
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Urinary Bladder Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Verapamil
General subdivision analogs & derivatives
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Dolderer, J H
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Schoch, C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bickeböller, R
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Woodcock, B G
773 0# - HOST ITEM ENTRY
Title International journal of clinical pharmacology and therapeutics
Related parts vol. 38
-- no. 4
-- p. 204-8
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.5414/cpp38204">https://doi.org/10.5414/cpp38204</a>
Public note Available from publisher's website

No items available.